Category: Headlines

The Wall Street Journal: Eli Lilly “will spend $5.3 billion to boost manufacturing capacity for its hot-selling anti-obesity drug Zepbound and cousin diabetes drug Mounjaro, a huge investment to ease shortages of the popular drugs.” https://www.wsj.com/health/pharma/eli-lilly-boost-supply-mounjaro-zepbound-weight-loss-drugs-d7060ef2?mod=pls_whats_news_us_business_f IndieWire: Daniel Radcliffe “told E! News that he and his fellow original actors will probably not appear in the…